Neurocrine Biosciences (NASDAQ: NBIX) disclosed in an SEC filing: On October 18, 2017, David-Alexander C. Gros, M.D. resigned as the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE